---
$id: https://graph.org.ai/products/commodity/51111745
$type: Product
source: UNSPSC
code: "51111745"
title: "Gemtuzumab"
class: "51111700"
classTitle: "Antineoplastic antibiotics"
family: "51110000"
familyTitle: "Antineoplastic agents"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Gemtuzumab

**UNSPSC Code**: 51111745
**Class**: [Antineoplastic antibiotics](Antineoplastic antibiotics.mdx)
**Family**: [Antineoplastic agents](../Antineoplastic agents.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an anti-cd33 immunotoxin, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 8GZG754X6M. European Medicines Agency schedules Gemtuzumab ozogamicin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB20794. Gemtuzumab generally arises in the molecular formula C73H96IN6O25S3. The term GEMTUZUMAB is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 15 no. 1, 2001, list 45.) Most nations schedule Gemtuzumab under HS 30021091 and SITC 54163. SMILES:. As of Q4 2014, GEMTUZUMAB remains the US FDA Preferred Term for this commodity. .

